Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™

NCT00654901 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

881

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Poliomyelitis
Haemophilus Influenzae Type B Infection

Interventions

BIOLOGICAL: DTaP-IPV-Hep B-PRP~T vaccine (Batch 1)
BIOLOGICAL: DTaP-IPV-Hep B-PRP~T vaccine (Batch 2)
BIOLOGICAL: DTaP-IPV-Hep B-PRP~T vaccine (Batch 3)
BIOLOGICAL: Infanrix Hexa™

Sponsor

Sanofi Pasteur, a Sanofi Company